Form 1-A/A — Nok Therapeutics, Inc.
0001213900-24-111515 · filed Dec 23, 2024
Offering
- Total offering
- —
- Total sold
- —
- Security type
- —
- Price per security
- $2.0000
- Over-allotment
- —
- Jurisdictions
- —
Issuer
- CIK
- 2038166
- Entity
- Corporation
- Jurisdiction
- FLORIDA
- Address
- 2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066
Most recent fiscal year financials
Financial statement requirements vary by tier and report. Verify the audit or review status in the original SEC filing.
- Total assets
- $12,000
- Total liabilities
- $173,363
- Cash
- —
- Total revenues
- $0
- Net income
- $-163,363
Same issuer's Form D filings
View the original filing on SEC EDGAR ↗